01 / The founder
Biography
Co-founder and CTO of Ripple Therapeutics, a Toronto biotech developing the Epidel prodrug sustained drug-delivery platform, following the sale of Interface Biologics to Evonik in 2019.
02 / Editorial
Why we're watching
Deeply experienced medtech/biotech executive with a prior successful exit (Evonik acquisition), making her more an established repeat-founder than an emerging one.
03 / The company
Ripple Therapeutics
Medtech · Canada · growth
04 / Verification
What we verified
Confirmed co-founder/CTO; leadership has prior successful exit history, reducing 'rising/unknown' fit despite company being real and operating.
05 / References